Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | cytochrome b | 0.0521 | 0.5 | 0.5 |
Plasmodium vivax | cytochrome b | 0.0521 | 0.5 | 0.5 |
Toxoplasma gondii | apocytochrome b, putative | 0.0521 | 0.5 | 0.5 |
Loa Loa (eye worm) | cytochrome b | 0.0521 | 0.5 | 0.5 |
Echinococcus granulosus | cytochrome B | 0.0521 | 0.5 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0521 | 0.5 | 0.5 |
Plasmodium falciparum | cytochrome b | 0.0521 | 0.5 | 0.5 |
Schistosoma mansoni | cytochrome b | 0.0521 | 0.5 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | cytochrome b subunit of the bc complex | 0.0521 | 0.5 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.